Cerebellar Abiotrophy (CA)
Gene or Region: MUTYH
Reference Variant: C
Mutant Variant: T
Affected Breeds: Arabian and Other Breeds
Research Confidence: High Confidence - Findings reproduced in multiple studies
Explanation of Results: ca/ca = homozygous for Cerebellar Abiotrophy, trait expressed ca/n = heterozygous for Cerebellar Abiotrophy, carrier n/n = no variant detected
General Description for Cerebellar Abiotrophy
Cerebellar Abiotrophy (CA) is a degenerative neurological disorder due to the death of large neurons (Purkinje cells) in the cerebellum. Foals affected by CA begin show symptoms between 6 weeks and 4 months of age. These horses display head tremors, lack of coordination, wide stances, exaggerated gait, difficulty rising, and startle easily. As this disease is an autosomal recessive condition, a horse must inherit two copies of the allele (ca/ca) to show any signs. Horses with only one copy of the allele (ca/n) are known as carriers due to their ability to produce affected foals.
Here is a video taken at the University of Zurich in 1992 of a CA/CA foal.
Gene Information
MUTYH is an enzyme that functions to repair oxidative damage, and is expressed at high levels in the brain. Although many other species are also affected by CA, the horse is the only one associated with mutations in this gene. This particular mutation is located a short distance from MUTYH, and is likely involved in its regulation.
References
Brault LS et al., “Mapping of equine cerebellar abiotrophy to ECA2 and identification of a potential causative mutation affecting expression of MUTYH.” (2011) Genomics. 97: 121-9. PMID: 21126570
Brault LS and Penedo MC, “The frequency of the equine cerebellar abiotrophy mutation in non-Arabian horse breeds.” (2011) Equine Vet J. 43: 727-31. PMID: 21496100
Cavalleri JM et al., “Morphometric magnetic resonance imaging and genetic testing in cerebellar abiotrophy in Arabian horses.” (2013) BMC Vet Res. 9: 105. PMID: 23702154
Tarr CJ et al., “The carrier prevalence of severe combined immunodeficiency, lavender foal syndrome and cerebellar abiotrophy in Arabian horses in South Africa.” (2014) Equine Vet J. 46: 512-4. PMID: 24033554
More Horse Health
Equine Recurrent Uveitis Risk and Severity
Equine Recurrent Uveitis (ERU) is the most common cause of blindness in horses, affecting about 3-15% of the horse population worldwide. Characterized by episodes of inflammation of the middle layer of the eye, Equine Recurrent Uveitis in horses leads to the development of cataracts, glaucoma and eventually complete loss of vision.
Foal Immunodeficiency Syndrome
Foal immunodeficiency syndrome (FIS) is a failure in the development of the adaptive immune system. At 3-6 weeks of age, once the maternal antibodies begin to degrade, foals exhibit signs of anemia, diarrhea, and pneumonia. As these foals fail to respond to treatment for infections, they are humanely euthanized at a young age.
Glanzmann Thrombasthenia
Glanzmann Thrombasthenia (GT) is a blood platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings.
Glycogen Branching Enzyme Deficiency
Glycogen Branching Enzyme Deficiency (GBED) is a lethal recessive disorder characterized by seizures, muscle weakness, respiratory failure, and death. Many affected foals do not make it full term and are aborted or stillborn. Carriers (gbed/n) have no known issues.